U.S. flag An official website of the United States government
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. WR Group, Inc. - 524181 - 10/31/2018
  1. Warning Letters

CLOSEOUT LETTER

WR Group, Inc. MARCS-CMS 524181 —


Recipient:
Recipient Name
Carey Williams
Recipient Title
CEO/Owner
WR Group, Inc.
WR Group, Inc.

9160 Bahia Drive
Suite 200
Scottsdale, AZ 85260
United States

Issuing Office:
Center for Food Safety and Applied Nutrition

Office of Human and Animal Food Operations - Division IV West
United States


Dear Mr. Williams:

The Food and Drug Administration has completed an evaluation of your corrective actions in response to our Warning Letter HAFW4(DEN)-17-19-WL, dated September 7, 2017. Based on our evaluation, it appears that you have addressed the violation(s) contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

Sincerely,
/S/
LaTonya M. Mitchell
Program Division Director
Office of Human and Animal Food Operations -
Division IV West